Besides PD-L1 expression levels on T cells and tumor cells, Liu et al. 10 found that high-level of PD-L1 expression on CD68+ macrophages correlated with longer OS in NSCLC patients treated with immunotherapy. Here, CD274 is linked to non-small cell lung carcinoma.